Introduction
Salt formation is the most general and effective method for improving the aqueous solubility and dissolution rate of acidic and basic drugs. Currently nearly half of all active pharmaceutical ingredients (APIs) used in medication are in salt forms. 1 However, during various processing steps such as milling, compression, drying, and granulation, a salt can become unstable chemically and physically, such that it may transform to its free acid/base form or into other polymorphs or solvates. Many of the commonly used excipients in tablet formulations are acidic or basic and can, thus, change the local pH of a system. This can affect the stability of the salt and cause the transformation of the salt to the corresponding free acid/base form. The solid-state transformation from a salt to a free form will alter key properties of the API, such as solubility and dissolution behavior, leading to undesired changes in the bioavailability of the API. 2 In order to monitor the quality of pharmaceuticals, an effective and highly sensitive quantitation method is required. A variety of techniques have been used to characterize the physicochemical properties of pharmaceuticals, 3 including powder X-ray diffraction (PXRD), differential scanning calorimetry (DSC), and vibrational spectroscopies, notably IR and Raman. Although PXRD is considered the definitive test for the identification of a specific solid-state form, the effectiveness of PXRD for quantitative analysis of mixtures of solid phases can be diminished when the effects of preferred orientation are significant 4 ; however, if the crystal structures of all the solid forms present in the mixture are known, then quantitative analysis can be carried out by Rietveld refinement in which the effects of preferred orientation are taken rigorously into consideration. For example, Li et al. 5 have shown that the error associated with distinguishing polymorphs I and II of sulfamerazine by DSC or PXRD was ±3%, which is superior to that achieved by Raman spectroscopy. Siddiqui et al. 6 have also used PXRD (and solid-state nuclear magnetic resonance [NMR] ) to quantify the amount of crystalline tacrolimus solid dispersions, 7 whereas Macfhionnghaile et al. 8 have investigated the effect of ball-milling and cryomilling on sulfamerazine using PXRD, IR, and near-IR spectroscopy. Using terahertz (THz) spectroscopy, 9 Strachan et al. 10 have shown that the concentration of carbamazepine form III in a physical mixture with form I can be detected down to a concentration of 1.5%. Moreover, Hisazumi et al. 11 have
used THz spectroscopy to distinguish between anhydrous and hydrate forms of theophylline with an error of 3% in a pharmaceutical formulation. Recently, Thakral et al. 12 have used PXRD to follow salt disproportionation, in which the PXRD data were measured using a 2-dimensional area detectordusing this technique, conventional 1-dimensional PXRD patterns that are free from the effects of preferred orientation can be obtained by appropriate integration of the 2-dimensional data. Solid-state NMR spectroscopy is an important method for pharmaceutical analysis. [13] [14] [15] [16] [17] Although the workhorse method is 13 C cross-polarization (CP) magic-angle spinning (MAS), the potential of applying 1 H fast MAS NMR is increasingly recognized for solid-state analysis. In particular, the 1 Hd o u b l e -q u a n t u m( D Q )s o l i d -s t a t e NMR experiment is a powerful probe of dipolar-coupled protons, with DQ peaks observed for close (typically less than 3.5 Å) throughspace H$$$H proximities. [49] [50] [51] Thus, a 2-dimensional 1 H DQ spectrum represents a "fingerprint" for a specific 3-dimensional packing arrangement adopted by an organic molecule, emphasizing the advantage over 1-dimensional 1 Ho r 13 C NMR spectra of spreading out into 2 dimensions. In this way, by using a high-resolution 1 HDQ combined rotation and multiple-pulse spectroscopy (CRAMPS) approach, 52 it has been shown how the presence of only the anhydrous form and not a hydrate form of an API in tablet formulation can be established. 19 However, due to the spectral noise associated with the application of 1 H homonuclear decoupling in the CRAMPS approach, it is only possible to conclude that the hydrate form is absent within a detection limit of~5% for the spectra presented in the study by Griffine ta l . 19 An alternative approach is to use a combination of fast MAS and high magnetic field to give 1 HDQMAS spectra, where the resolution, although not as good as with the 1 H DQ CRAMPS method, 51 is sufficient to resolve distinct spectral features. For the specific case of the anhydrous HCl salt of cimetidine (the crystal structure of which has been determined recently 53 by a combined PXRD and NMR crystallography strategy) and the free form of cimetidine (anhydrous polymorph A), this article investigates the lower limit of detection of a minority solid-state form of an API, present in a physical mixture with another crystalline phase of the same API, using 1 H DQ MAS NMR spectroscopy.
Experimental Section
Cimetidine and cimetidine hydrochloride were purchased from Sigma-Aldrich and used without further purification. The identification of the specific solid-state form was confirmed by PXRD as shown in the studies by Tatton et al. 33 and Watts et al. 53 Samples containing 10%, 5%, 1%, and 0.5% w/w polymorph A/anhydrous HCl salt were prepared by physically mixing appropriately weighed quantities of the 2 pure solid phases. Solid-state NMR experiments were performed on a Bruker Avance III spectrometer operating at a Table 1, while Tables 2 and 3 in double-resonance mode, supporting rotors of 2.5 mm outer diameter (corresponding to~10 mg of sample). An MAS frequency of 30 kHz was used. The pulse sequence and coherence transfer pathway diagram for the 1 HD QM A S 49 experiment using back-toback recoupling 54, 55 are shown in Figure 7 of the review by Brown and Spiess. 56 A 16-step phase cycle was used to select Dp ¼ ±2onthe DQ excitation block and Dp ¼À 1onth efinal 90 pulse, where p is the coherence order. The 1 H9 0 pulse duration was 2.5 ms. In all experiments, 160 t 1 FIDs were recorded with a rotor-synchronized t 1 increment of 33.3 ms using the States time-proportional phase incrementation method to achieve sign discrimination in F 1 . For the anhydrous HCl salt of cimetidine and polymorph A of cimetidine, 16 transients were co-added with a recycle delay of 3 s. For the physical mixtures of polymorph A and the anhydrous HCl salt, a recycle delay of 9 s was used and 16 (10% and 5% w/w mixture samples), 48 (1% w/ w mixture sample), and 112 (0.5% w/w mixture sample) transients were co-added. The experimental times were thus 2 h (anhydrous cimetidine hydrochloride and cimetidine polymorph A), 6 h (10% and 5% w/w mixture samples), 19 h (1% w/w mixture sample), and 44 h (0.5% w/w mixture sample).
1 H chemical shifts are referenced with respect to neat TMS using adamantane as a secondary reference (1.85 ppm for 1 H). 57 Experimental 1 H chemical shifts are stated to an accuracy of ±0.1 ppm.
Results and Discussion

H DQ MAS Solid-State NMR Spectra
In previous studies, 1-dimensional 13 C CP MAS NMR spectra, as well as the results of various heteronuclear dipolar experiments, have been presented for a free form of cimetidine (polymorph A), 58, 59 whereas a 13 C CP MAS spectrum of the anhydrous HCl salt of cimetidine as well as a gauge-including projector-augmented wave (GIPAW) calculation 60, 61 of the NMR parameters (for the reported crystal structure following geometry optimization) have been presented recently. 53 Tatton et al. 33 have also presented 15 3 mm and less) . However, the improved resolution would come at the cost of lower sensitivity associated with the considerably reduced sample volume (corresponding to sample mass~1 mg or less). Enhanced resolution could also be achieved using the 1 H DQ CRAMPS approach (e.g., see Fig. 3 of the review by Brown 51 ) but, as noted in the Introduction, the disadvantage of using 1 H homonuclear decoupling is the observation of additional "noise" in the spectra which limits the lower detection of the minority phase to~5%. For these reasons, it was decided that 30-kHz MAS at a 1 H Larmor frequency of 850 MHz provided the best compromise of sufficiently high-resolution and optimum sensitivity for 1 H DQ MAS NMR spectroscopy of the anhydrous HCl salt and polymorph A of cimetidinedsee the spectra presented in Figures 1a and 1b . Intermolecular proximities are in italics. a Distances are stated for the geometry-optimized (CASTEP) crystal structure. observed at the sum of the 2 single-quantum (SQ) frequencies. Figure 1a Table 2 . We also note the very weak diagonal Figure 1a that corresponds to a 3.43 Å intermolecular proximity of the NH þ (H1) and NH (H3) protons (also see Table 2 ). As described in the study by Bradley et al., 65 to a first approximation, the relative intensity of distinct 1 Tables 2 and 3) .
This study is focused on the pair of 1 H DQ peaks due to the intramolecular proximity of 2.57 and 2.55 Å for the imidazole H2
(CH) and H3 (NH) protons, whereby d DQ ¼ 15.0 þ 9.4 ¼ 24.4 ppm in Figure 1a for the anhydrous HCl salt and d DQ ¼ 11. 6 þ 7.4 ¼ 19.0 ppm in Figure 1b for polymorph A. The evident change in the positions of the pair of 1 H DQ peaks due to the intramolecular proximity of the imidazole H2 (CH) and H3 (NH) protons between the anhydrous HCl salt and polymorph A constitutes a "fingerprint" that is a diagnostic for the presence of either or both of the distinct solidstate forms.
Probing the Level of Detection of a Minority Phase in a Physical Mixture of 2 Distinct Crystalline Phases
To determine the level of detection by 1 H DQ MAS NMR of polymorph A of cimetidine in a physical mixture with the anhydrous HCl salt of cimetidine, spectra were recorded for samples comprising 10%, 5%, 1%, and 0.5% w/w mixtures of polymorph A/ anhydrous HCl salt. Specifically, Figure 1c presents a 1 H DQ MAS NMR spectrum of the 10% w/w mixture (note the lower base contour in Fig. 1c as compared to Figs. 1a and 1b) . It is evident that a weak pair of 1 H DQ peaks at d DQ ¼ 11. 6 þ 7.4 ¼ 19.0 ppm due to ppm, it is observed that the 1 H DQ peaks due to polymorph A are still evident above the noise level down to the 1% w/w mixture in Figure 2e . This conclusion is confirmed by the signal-to-noise analysis presented in Table 4 67, 68 Moreover, it has recently been shown that the sensitivity of solidstate NMR spectroscopy of moderately sized organic molecules can be significantly enhanced (e.g., by 5 times for paracetamol) by employing dynamic nuclear polarization, such that 13 Cr e f o c u s e d INADEQUATE spectra can be recorded at natural isotopic abundance in 16 h for sulfathiazole (which has a long T 1 relaxation time, necessitating a recycle delay of 30 s) 69 H correlation spectra can be obtained also at natural isotopic abundance for a pharmaceutical formulation. 70 With the recent development of new dynamic nuclear polarization 1.3-mm MAS probe technology that allows faster MAS, 71 this approach seems promising for progressing to even lower levels of detection of minority solid-state forms by 1 H DQ MAS. This approach would also reduce the required experimental time (in this work, 19 h for the 2-dimensional spectrum of the 1% w/w sample), noting that experimental times are typically shorter for other techniques such as PXRD, Raman, and IR. Finally, as shown in our earlier work employing a 
